The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Learn how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual ...

The biotech market is still going strong as more startups focused on therapeutic research crop up. Just this week, Italian startup Aptadir Therapeutics launched with $1.6 million to bring a new class ...